Wednesday, July 30, 2014 11:12:46 PM
This means to me that the outcoming data of LYMPRO is at the top end, is at his best at the very moment.
Be honest we all believe and are convinced, some more then others but we are all convinced that Gerald is the right (PR)man for AMBS.
Why should he lie to his investors at such a crucial moment? I say it again that make no sence.
I have never met a CEO before who is so open in his policy.
He provides us with every detail he knows at the right moment.
Should he missed some detail. Is he going to tell us that Lympro is not going this year but next to the Market?
NO. All the details are already on the table for a while.
He knows how to put AMBS on the road to commercialisation.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM